2018
DOI: 10.1007/112_2017_8
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Like Growth Factor 1 in the Cardiovascular System

Abstract: Non-communicable diseases, such as cardiovascular diseases, are the leading cause of mortality worldwide. For this reason, a tremendous effort is being made worldwide to effectively circumvent these afflictions, where insulin-like growth factor 1 (IGF1) is being proposed both as a marker and as a central cornerstone in these diseases, making it an interesting molecule to focus on. Firstly, at the initiation of metabolic deregulation by overfeeding, IGF1 is decreased/inhibited. Secondly, such deficiency seems t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 242 publications
7
15
0
1
Order By: Relevance
“…According to Aguirre et al, at the initiation of metabolic dysregulation by overfeeding, IGF-1 is decreased. Such defi ciency seems to be related to the onset of MS and atherosclerosis (19). In agreement with these previous data, our study confi rmed that IGF-1 is inversely related to metabolic parameters of carbohydrates and lipids, suggesting its protective role in the metabolic syndrome associated with PCOS.…”
supporting
confidence: 91%
“…According to Aguirre et al, at the initiation of metabolic dysregulation by overfeeding, IGF-1 is decreased. Such defi ciency seems to be related to the onset of MS and atherosclerosis (19). In agreement with these previous data, our study confi rmed that IGF-1 is inversely related to metabolic parameters of carbohydrates and lipids, suggesting its protective role in the metabolic syndrome associated with PCOS.…”
supporting
confidence: 91%
“…Insulin-like growth factor 1 (IGF-1) has a vital function in maintaining the structure and function of the body ( 15 , 16 ). Recently, IGF-1 was revealed to be closely associated with the development and growth of cardiomyocytes by promoting cell growth and resisting cell death ( 17 ). Therefore, the secretion of IGF-1 by MSCs may be an effective strategy to retard myocardial I/R injury.…”
Section: Introductionmentioning
confidence: 99%
“…For this reason, IGF-1 deficiency has a central role in this whole process, as it is one of the most potent antiapoptotic, antioxidant and cytoprotective factors known today. Moreover, IGF-1 is also known to have vasodilator actions [19]. IGF-1 regulates cell proliferation, apoptosis, migration and differentiation, so it is a potent mitogen factor for vascular smooth cells to stimulate migration and antiapoptotic effects of VSMC [20].…”
Section: Discussionmentioning
confidence: 99%